Last reviewed · How we verify
NCT06850142
A Comparative Study Between TMJ Discopexy to External Ear Cartilage Versus to Temporal Fascia
NA trial testing Discopexy to external ear cartilage in Temporomandibular Joint Disc Displacement in 22 participants. Completed in 22 January 2025.
19 July 2024
Quick facts
| Lead sponsor | Fayoum University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 22 |
| Start date | 5 January 2022 |
| Primary completion | 19 July 2024 |
| Estimated completion | 22 January 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Discopexy to external ear cartilage
- Discopexy to temporal fascia
Conditions studied
- Temporomandibular Joint Disc Displacement — all drugs for Temporomandibular Joint Disc Displacement →
- Temporomandibular Joint Disc Displacement, Without Reduction — all drugs for Temporomandibular Joint Disc Displacement, Without Reduction →
Sponsor
Fayoum University
Who can join
Adults 35 to 60, any sex, with Temporomandibular Joint Disc Displacement or Temporomandibular Joint Disc Displacement, Without Reduction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Discopexy is a surgical procedure aimed at stabilizing the articular disc within the temporomandibular joint (TMJ) in patients experiencing TMJ disorders (TMD). The TMJ is a complex joint responsible for jaw movement, and its proper function relies on the alignment and stability of the articular disc, a fibrocartilaginous structure that cushions the joint. In cases of disc displacement or dysfunction, patients may experience pain, clicking, limited jaw movement, and other symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06850142
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Fayoum University trials
Trials by the same sponsor.
- NCT07536620 — Metformin and Alveolar Cleft · Phase 2 · not yet recruiting
- NCT07444970 — Comparative Evaluation of Xenograft Alone and Sticky Bone in Sinus Lift With Concurrent Implant Placement · NA · not yet recruiting
- NCT07394179 — Transforming Channel Osteotomy Into Tunnel Osteotomy in Zygomatic Implant Preparation · NA · not yet recruiting
- NCT07277348 — Analysis of The Outcomes of Therapeutic Photorefractive Keratectomy Combined With Prophylactic Accelerated Cross-Linking · NA · not yet recruiting
- NCT07330726 — Lidocaine Patch and Lower Third Molar · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06850142 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fayoum University
- Last refreshed: 27 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06850142.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing